Chemistry: molecular biology and microbiology – Virus or bacteriophage – except for viral vector or...
Patent
1994-06-22
1996-09-10
Budens, Robert D.
Chemistry: molecular biology and microbiology
Virus or bacteriophage, except for viral vector or...
4353201, 536 2372, 536 241, 4241991, C12N 700, C12N 701, C12N 1500, C12N 1509
Patent
active
055545246
ABSTRACT:
Chimeric retroviral vectors were constructed containing the long terminal repeats (LTRs) from a simple retrovirus (e.g. spleen necrosis virus (SNV); murine leukemia virus (MLV)) devoid of the integration site (att) and more complex retroviral (e.g. bovine leukemia virus (BLV); human immunodeficiency virus (HIV)) cis-acting regulatory sequences (e.g. att; primer binding site (PBS); encapsidation site (E), and polypurine tract (ppt)) and coding regions. Cells transfected with these constructs produce replication competent retrovirus particles. These retroviral particles provide a source of viral antigens that can be employed in both diagnostic assays and as immunogens for the production of high-titer specific antisera.
REFERENCES:
patent: 4650764 (1987-03-01), Temin et al.
patent: 4980289 (1990-12-01), Temin et al.
patent: 5124263 (1992-06-01), Temin et al.
Brenner, M., 1994 Immunomethods 5:204-210.
Leiden, J., 1995 New Engl. J. Med. 333:871-873.
Mulligan, R., 1993 Science 260:926-932.
Norley, S. et al. Immunobiol. "Vaccination Against HIV" 184: 193-207 (1992).
Temin, H. M. 1990. "Safety considerations in somatic gene therapy of human disease with retrovirus vectors". Hum. Gene. Ther. 1:111-123.
Ellis, R. W. 1988. "New technologies for making vaccines". In: Vaccines, Plotkin & Mortimer Eds. W. B. Saunders Co. pp. 568-575.
J. Dougherty et al., 168 Mol. Cel. Biol. 4387-4395 (1986).
J. Dougherty et al., 63 J. Virol. 3209-3212 (1898).
H. Temin et al., The Retroviridae, vol. 1, p. 1-17 (1992).
T. Matthews et al., Sci. Am. 120-127 (Oct., 1988).
D. Montefiori et al., 64 J. Virol. 5223-5225 (1990).
M. Marthas et al., 64 J. Virol. 3694-3700 (1990).
P. Marx et al., 60 J. Virol. 431-435 (1986).
M. Seiki et al., 80 P.N.A.S. USA 3618-3622 (1983).
D. Derse et al., 64 J. Virol. 401-405 (1990).
N. Sagata et al., 80 P.N.A.S. USA 677-681 (1985).
R. Weiss et al., RNA Tumor Viruses, pp. 766-785, appendix (2d Edition 1985) (Cold Spring Harbor).
J. Salk et al., 83 Annals NY Acad. Sci. 609-636 (1960).
A. Allison et al., 95 J. Immun. Met. 157-168 (1986).
M. Daniel et al., 258 Science 1938-1941 (1992).
R. Desrosiers, 8 AIDS Res. Human Retrovir. 411-421 (1992).
I. Ghattas et al., 11 Mol. Cel. Biol. 5848-5859 (1991).
F. Moolten et al., 82 J. Nat. Can. Inst. 297-300 (1990).
C. Mullen et al., 89 P.N.A.S. USA 33-37 (1992).
P. Southern et al., 1 J. Mol. Appl. Gene. 327-341 (1982).
C. Yanisch-Perrson et al., 33 Gene 103-119 (1985).
A. Miller, 1 Humn. Gen. Ther. 5-14 (1990).
Boris-Lawrie Kathleen A.
Temin Howard M.
Budens Robert D.
Parkin Jeffrey S.
Wisconsin Alumni Research Foundation
LandOfFree
More complex type retroviruses having mixed type LTR, and uses t does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with More complex type retroviruses having mixed type LTR, and uses t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and More complex type retroviruses having mixed type LTR, and uses t will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1319922